Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.47015 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.43784 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.73756 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.30383 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.44304 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.49933 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.46236 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.55734 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.45386 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.42182 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.41933 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.51076 | 59 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.42308 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.53349 | 59 |